Paballo Mosala
University Of Cape Town
Cape Town, WC, South Africa
Cape Town, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: PLOS global public health
Published: December 04, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: medRxiv : the preprint server for health sciences
Published: December 04, 2023
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant.
Journal: Cell host & microbe
Published: October 27, 2023
Cysteinyl leukotriene receptor-1 as a potential target for host-directed therapy during chronic schistosomiasis in murine model.
Journal: Frontiers in immunology
Published: August 17, 2023
Environmental and microbial factors influence affective and cognitive behavior in C57BL/6 sub-strains.
Journal: Frontiers in immunology
Published: January 07, 2023
Type 2 immunity: a two-edged sword in schistosomiasis immunopathology.
Journal: Trends in immunology
Published: May 23, 2022
Schistosoma mansoni infection induces plasmablast and plasma cell death in the bone marrow and accelerates the decline of host vaccine responses.
Journal: PLoS pathogens
Published: September 03, 2021
Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection.
Journal: Frontiers in immunology
Published: July 27, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026